136 related articles for article (PubMed ID: 37928300)
1. Relapsed urachal carcinoma responding to first-line chemotherapy with capecitabine-oxaliplatin plus bevacizumab.
Hatano A; Wakaki K; Miyajima N; Komatsu S
IJU Case Rep; 2023 Nov; 6(6):345-348. PubMed ID: 37928300
[TBL] [Abstract][Full Text] [Related]
2. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
3. Surgical and chemotherapeutic experience regarding a urachal carcinoma with repeated relapse: case report and literature review.
Zong L; Chen P
World J Surg Oncol; 2013 Aug; 11():170. PubMed ID: 23914849
[TBL] [Abstract][Full Text] [Related]
4. A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus Bevacizumab.
Kanamaru T; Iguchi T; Yukimatsu N; Shimizu Y; Kohyama Y; Tachibana H; Kato M; Yamasaki T; Tamada S; Nakatani T
Urol Case Rep; 2015 Mar; 3(2):9-11. PubMed ID: 26793485
[TBL] [Abstract][Full Text] [Related]
5. Urachal carcinoma: A case of a rare neoplasm.
Moreira I; Coelho S; Rodrigues Â; Patrão AS; Maurício MJ
Curr Probl Cancer; 2021 Dec; 45(6):100711. PubMed ID: 33541722
[TBL] [Abstract][Full Text] [Related]
6. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
de Gramont A; Van Cutsem E; Schmoll HJ; Tabernero J; Clarke S; Moore MJ; Cunningham D; Cartwright TH; Hecht JR; Rivera F; Im SA; Bodoky G; Salazar R; Maindrault-Goebel F; Shacham-Shmueli E; Bajetta E; Makrutzki M; Shang A; André T; Hoff PM
Lancet Oncol; 2012 Dec; 13(12):1225-33. PubMed ID: 23168362
[TBL] [Abstract][Full Text] [Related]
8. Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor.
Chen M; Xue C; Huang RQ; Ni MQ; Li L; Li HF; Yang W; Hu AQ; Zheng ZS; An X; Shi Y
Front Oncol; 2021; 11():739134. PubMed ID: 34604084
[TBL] [Abstract][Full Text] [Related]
9. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.
Nagasaka T; Mishima H; Sawaki A; Shimokawa M; Inukai M; Shinozaki K; Tanioka H; Nasu J; Nishina T; Hazama S; Okajima M; Yamaguchi Y
BMJ Open; 2016 Jun; 6(6):e011454. PubMed ID: 27256093
[TBL] [Abstract][Full Text] [Related]
10. Case Report: A case of advanced duodenal adenocarcinoma in complete remission after chemotherapy combined with targeted therapy and radiotherapy.
Zhang Z; Lei Y; Wang D; Yang L; Lou C
Front Oncol; 2022; 12():968110. PubMed ID: 36353566
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study.
Di Bartolomeo M; Ciarlo A; Bertolini A; Barni S; Verusio C; Aitini E; Pietrantonio F; Iacovelli R; Dotti KF; Maggi C; Perrone F; Bajetta E
Eur J Cancer; 2015 Mar; 51(4):473-481. PubMed ID: 25637137
[TBL] [Abstract][Full Text] [Related]
12. [A case of urachal carcinoma treated with S-1/CDDP combination chemotherapy].
Sekita N; Fujimura M; Arai H; Shibata N; Nishikawa R; Sugano I; Mikami K
Hinyokika Kiyo; 2010 Aug; 56(8):447-51. PubMed ID: 20808064
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer.
Bazarbashi S; Aljubran A; Alzahrani A; Mohieldin A; Soudy H; Shoukri M
Cancer Med; 2015 Oct; 4(10):1505-13. PubMed ID: 26207614
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Uronis HE; Bendell JC; Altomare I; Blobe GC; Hsu SD; Morse MA; Pang H; Zafar SY; Conkling P; Favaro J; Arrowood CC; Cushman SM; Meadows KL; Brady JC; Nixon AB; Hurwitz HI
Oncologist; 2013; 18(3):271-2. PubMed ID: 23485624
[TBL] [Abstract][Full Text] [Related]
15. Multicenter phase II clinical study of the efficiency and safety of capecitabine plus intermittent oxaliplatin with bevacizumab as first-line therapy in patients with metastatic colorectal cancer (VOICE trial).
Kosugi C; Koda K; Denda T; Ishibashi K; Ishida H; Seike K; Sakata H; Yanagisawa S; Miyazaki A; Takayama W; Koike N; Shimizu H; Matsubara H
Int J Colorectal Dis; 2021 Dec; 36(12):2637-2647. PubMed ID: 34368890
[TBL] [Abstract][Full Text] [Related]
16. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Hegewisch-Becker S; Graeven U; Lerchenmüller CA; Killing B; Depenbusch R; Steffens CC; Al-Batran SE; Lange T; Dietrich G; Stoehlmacher J; Tannapfel A; Reinacher-Schick A; Quidde J; Trarbach T; Hinke A; Schmoll HJ; Arnold D
Lancet Oncol; 2015 Oct; 16(13):1355-69. PubMed ID: 26361971
[TBL] [Abstract][Full Text] [Related]
17. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
18. [Super-Elderly Patient with Recurrent Rectal Cancer with Liver Metastases Effectively Treated with Capecitabine plus Bevacizumab Chemotherapy--Report of a Case].
Miyazaki Y; Miyazaki S; Fujita S; Hirose H; Sugimoto S; Michiura T; Yamabe K; Nagaoka M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2279-81. PubMed ID: 26805337
[TBL] [Abstract][Full Text] [Related]
19. Breast metastasis of signet ring cell carcinoma from the colon: a case report.
Wang X; Zhang H; Lu Y
World J Surg Oncol; 2022 Dec; 20(1):376. PubMed ID: 36451153
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine, Oxaliplatin, Irinotecan, and Bevacizumab Combination Followed by Pazopanib Plus Capecitabine Maintenance for High-Grade Gastrointestinal Neuroendocrine Carcinomas.
Alifieris CE; Griniatsos J; Delis SG; Nikolaou M; Avgoustou C; Panagiotidis MI; Souferi-Chronopoulou E; Trafalis DT
Am J Clin Oncol; 2020 May; 43(5):305-310. PubMed ID: 32343515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
